Posted by DeAnn Dennis on Wed, Mar 29, 2023 @ 11:45 AM
A bipartisan group of House lawmakers introduced the Ensuring Patient Access to Critical Breakthrough Products Act. The legislation aims to close a gap between Food and Drug Administration (FDA) clearance of a breakthrough medical device and when the Centers for Medicare & Medicaid Services (CMS) covers it for Medicare.
The agency is providing a 180-day transition period for devices that were exempted during the pandemic, and said companies that currently have an EUA should start preparing.
The acquisition is among several made by CVS Health to extend into healthcare services. When the deal was announced in September, executives touted Signify Health’s home health business.
Nuance says the new application, Dragon Ambient eXperience (DAX) Express, is the first fully automated clinical documentation application to combine conversational and ambient AI with the advanced reasoning and natural language capabilities of OpenAI’s GPT-4.
Tags: Weekly Industry News
©2016. Avicenna Medical Systems All Rights Reserved.